Tag: biosimilars

How to Reduce Costs for Specialty Medications and Injectables: Proven Strategies for Employers and Patients 3 January 2026

How to Reduce Costs for Specialty Medications and Injectables: Proven Strategies for Employers and Patients

Specialty medications cost thousands per month, but proven strategies like biosimilars, narrow pharmacy networks, and treatment setting changes can slash costs by 30% or more without sacrificing care.

Interchangeability: When Biosimilars Can Be Substituted Automatically in the U.S. 1 January 2026

Interchangeability: When Biosimilars Can Be Substituted Automatically in the U.S.

Interchangeable biosimilars can be automatically swapped for brand-name biologics by pharmacists in the U.S.-but only if approved by the FDA and allowed by your state. Learn how it works, who benefits, and what patients need to know.